ICON plc in the news
Drug development consulting and services
Tamtam found 20 recent articles about ICON plc.
- ICON PLC (ICLR) Is Leveraging AI to Accelerate Clinical Trials
Riverwater Partners added ICON Public Limited Company to its Sustainable Value Strategy in Q3 2026 due to its attractive valuation and effective use of AI in clinical trial operations.
- U.S. Markets Rose Wednesday; Icon PLC Topped Leaders
U.S. stock indexes rose Wednesday, with the S&P 500, NASDAQ, and Dow all seeing gains, and Icon PLC performing well.
- Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
Icon PLC reported Q3 earnings of $2.66 per share and revenues of $2.02 billion, both exceeding analyst expectations, but its stock performance and future outlook are underperforming.
- Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Analysts expect Icon PLC's Q3 2026 earnings and revenue to decline year-over-year, with EPS projected at $2.64 and revenue at $2.01 billion.
- Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR
MarketBeat calculates consensus analyst ratings and price targets for stocks like ICON plc by normalizing and averaging individual analyst assessments.
- BofA Securities Upgrades Icon PLC (ICLR) to Neutral, Lifts Price Target Amid Positive CRO Outlook
BofA Securities upgraded Icon PLC to neutral with an increased price target, driven by positive expectations for the contract research organization sector and biopharma R&D spending.
- ICON plc Stock 12‑Month Price Target Raised to $187.81, Implies 14% Upside
Analysts raised their average price target for ICON plc stock to $187.81, implying a 14% upside, while maintaining a "Buy" consensus rating.
- Results arrive after market close October 27 for ICON (ICLR), with an earnings call October 28.
ICON plc (ICLR) will release its Q3 2026 financial results on October 27, 2026, with a follow-up conference call the next day.
- Is Icon PLC (ICLR) a Bargain After 3.9% Drop? GF Value Says Unde
Icon PLC's stock fell 3.9%, and while it appears undervalued by GF Value™ at $161.69, its high P/E ratio and insider selling suggest investor caution.
- ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings
ICON plc's stock increased by 3.5% as investors reacted to reaffirmed guidance, strong Q2 2026 results, and a positive September financial filing.
- S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag
S&P 500 futures are rising while OceanaGold Corp. and Krystal Biotech Inc. are up, but Xenon Pharmaceuticals and ICON PLC are lagging in pre-market trading.
- White & Case advises ICON on its US$2.15 billion notes offering and related secured debt refinancing
ICON plc issued $2.15 billion in notes through a subsidiary to refinance existing secured debt and redeem 2027 notes.
- Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC reported a miss on Q2 2026 adjusted earnings but beat revenue estimates, maintaining its full-year guidance despite recent downward estimate revisions.
- ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity
ICON Public Limited Company's stock surged 57% in Q2 2026 after releasing delayed financial results that clarified prior accounting issues related to revenue overstatements.
- Icon PLC (ICLR) Lags Q2 Earnings Estimates
ICON plc reported Q2 earnings of $2.56 per share, missing estimates by $0.01, while revenues of $2.06 billion surpassed expectations by 3.48%.
- Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?
Icon PLC's stock rose 5.8% after reporting Q1 2026 earnings that beat revenue and adjusted EPS estimates, although its Zacks Rank is a Strong Sell.
- Icon defends claim it left investors with ‘billions in losses’
Clinical trials firm Icon plc is facing a lawsuit from American pension funds over alleged investor losses.
- Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline
ICON plc (ICLR) is predicted to have a decline in Q2 earnings and revenues, with an expected EPS of $2.57 and revenues of $1.99 billion.
- ICON plc Selects Microsoft (MSFT) As Preferred Technology Partner
ICON plc selected Microsoft as its preferred technology partner to advance digital innovation and AI, deploying Microsoft 365 Copilot and leveraging Azure and Fabric to scale its AI platform Orbis and embed AI across clinical trials.
- Greenskeeper Asset Management Increased Its Holdings in ICON Plc (ICLR) Amid Market Fear
Greenskeeper Asset Management increased its stake in ICON plc during Q1 2026, viewing a stock drop caused by a revenue recognition investigation as an overreaction and the company as undervalued.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like ICON plc?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies